Indonesia to import 50 million doses of Covid-19 vaccines from China, SOEs Minister: It is technology transfer

Last updated on May 17th, 2021 at 11:43 am

PT Bio Farma (Persero) will receive 50 million doses of the Covid-19 Ready to Fill (RTF) vaccine bulk or concentrate from the Chinese biopharmaceutical company, Sinovac from November 2020 to March 2021.

This assurance was marked by the signing of the Preliminary Agreement of Purchase and Supply of Bulk Production of Covid-19 Vaccine, which was held in Hainan, China on August 20, 2020.

The Minister of SOEs and the Chief Executive of the Committee for Handling Covid-19 and National Economic Recovery (KPEN), Erick Thohir, said that in the agreement Bio Farma does not only process and distribute, but also includes technology transfer elements.

“Biofarma, working with Sinovac, is win-win cooperation. Bio Farma is not a tailor, there is an agreement with Sinovac called knowledge transfer, technology transfer. This needs to be underlined,” said Erick in an official statement received in Jakarta, Thursday, August 21.

Erick said the SOEs Ministry did not want Indonesia to be a consumptive country forever. Therefore, this transfer of technology and knowledge can make Indonesia more independent in the future, including the production of the coronavirus vaccine.

International cooperation in the field of vaccines, continued Erick, has become one of the government’s efforts to deal with the Covid-19 pandemic, including conducting 3T (test, trace, treat), encouraging behavior change.

In addition, preparing national independence through the development of Merah Putih vaccine and healing therapy, to preparing domestic production and distribution capacities for mass production and vaccination.

“While waiting for the Merah Putih vaccine, vaccines from other countries are still needed to protect Indonesian people so that ‘Health Recovers, Economy Rises’,” he added.

Previously, Erick Thohir said that the target of giving the Covid-19 vaccine to the public in early 2021 was a quick win for the government.

Related Article: https://www.theasianaffairs.com/indonesia/2020/08/15/bio-farma-states-merah-putih-vaccine-for-long-term-sinovac-for-short-term-dpr-member-asks-for-halalness-status-of-vaccine-from-china/

Noto

Jakarta-based Newswriter for The Asian Affairs. A budding newswriter that always keep track of the latest trends and news that are happening in my country Indonesia.

Recent Posts

China and UAE Celebrate 40 Years of Diplomatic Relations: All the Sectors for Partnership

Celebrating 40 years of diplomatic ties, China and the United Arab Emirates (UAE) are poised to fortify an alliance that…

November 2, 2024

What’s in Store for Squid Game Season 2: New Twists, International Adaptations, and a Bold Return to the Games

Fans of the worldwide sensation Squid Game have much to look forward to this December as the show's producer, Hwang…

November 2, 2024

TWICE Joins Coldplay’s ‘Music of the Spheres’ Tour for a Seoul Spectacle in 2025

Especially when it's the internationally known British rock band Coldplay linking up with K-pop phenomenon TWICE, few events match the…

November 2, 2024

China Caught in the Crossfire: Tensions Rise as North Korea and Russia Strengthen Alliance

Tucked on a 12-story structure in northeast China, visitors flock to get a rare view of the junction of their…

November 2, 2024

Could Westeros Dragons Soon Soar into the Big Screen? ‘Game of Thrones’ Film Reportedly in Early Development

HBO's Game of Thrones has created a void in the fantasy world of television that no other show has quite…

November 1, 2024

Preparing for U.S. Election Impact: Sen. Imee Marcos Urges Self-Reliant Defense Amid Uncertain Times

Head of the Senate Committee on Foreign Relations, Senator Imee Marcos underlined the need of the Philippines getting ready for…

November 1, 2024

This website uses cookies.

Read More